Literature DB >> 20149166

Assessment of a 27-kDa antigen in enzyme-linked immunosorbent assay for the diagnosis of fasciolosis in Vietnamese patients.

T G T Nguyen1, T H Le, N V De, T T Doan, T H T Dao, J Vercruysse, P Dorny.   

Abstract

Fasciolosis has emerged as an important zoonotic disease in many parts of the world. In recent years, an increasing number of human cases were reported in Vietnam. In this study, the 27-kDa component protein from the excretory/secretory production of adult Fasciola gigantica, purified by high performance liquid chromatography, was assessed in an enzyme-linked immunosorbent assay (ELISA) to detect antibodies against Fasciola spp. for diagnosis of human fasciolosis. The ELISA showed a high sensitivity (100%) and specificity (97.67%) when tested on patients with fasciolosis, other parasitic infections, cholangiocarcinoma and on healthy controls. The assay was applied for diagnosis on 143 patients in the Viet Duc-Hanoi hospital who presented with clinical signs of liver disease and lesions in their livers as shown by imaging techniques. Antibodies were found in 37 (25.9%) of these patients, of whom only 3 shed Fasciola eggs in their stools (2.1%). The excellent response to triclabendazole treatment of 37 sero-positive patients confirmed the diagnosis of fasciolosis. This study demonstrated the diagnostic potential for human fasciolosis of the 27-kDa antigen ELISA. Fasciolosis should be considered in the differential diagnosis of hepatic disease in Vietnam.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149166     DOI: 10.1111/j.1365-3156.2010.02468.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  8 in total

1.  Development of two antibody detection enzyme-linked immunosorbent assays for serodiagnosis of human chronic fascioliasis.

Authors:  Kimberly Cabán-Hernández; José F Gaudier; Caleb Ruiz-Jiménez; Ana M Espino
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

2.  Development and evaluation of a single-step duplex PCR for simultaneous detection of Fasciola hepatica and Fasciola gigantica (family Fasciolidae, class Trematoda, phylum Platyhelminthes).

Authors:  Thanh Hoa Le; Khue Thi Nguyen; Nga Thi Bich Nguyen; Huong Thi Thanh Doan; Xuyen Thi Kim Le; Chau Thi Minh Hoang; Nguyen Van De
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

Review 3.  Recent Developments in Recombinant Proteins for Diagnosis of Human Fascioliasis.

Authors:  Abolfazl Mirzadeh; Farid Jafarihaghighi; Elham Kazemirad; Shokouh Shahrokhi Sabzevar; Mohammad Hossein Tanipour; Mehdi Ardjmand
Journal:  Acta Parasitol       Date:  2020-09-24       Impact factor: 1.440

Review 4.  Immunodiagnosis of Human Fascioliasis: An Update of Concepts and Performances of the Serological Assays.

Authors:  Bahador Sarkari; Samaneh Abdolahi Khabisi
Journal:  J Clin Diagn Res       Date:  2017-06-01

5.  Immunodetection of Fasciola gigantica circulating antigen in sera of infected individuals for laboratory diagnosis of human fascioliasis.

Authors:  Abdelfattah M Attallah; Faisal A Bughdadi; Atef M El-Shazly; Hisham Ismail
Journal:  Clin Vaccine Immunol       Date:  2013-08-14

Review 6.  Early Postnatal and Preschool-Age Infection by Fasciola spp.: Report of Five Cases from Vietnam and Worldwide Review.

Authors:  Nguyen Van De; Thanh Hoa Le; Veronica H Agramunt; Santiago Mas-Coma
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

7.  Stunting in pre-school and school-age children in the Peruvian highlands and its association with Fasciola infection and demographic factors.

Authors:  Camille M Webb; Maria Luisa Morales; Martha Lopez; Benicia Baca-Turpo; Eulogia Arque; A Clinton White; Miguel M Cabada
Journal:  PLoS Negl Trop Dis       Date:  2021-06-21

8.  Dot-blot immunoassay of Fasciola gigantica infection using 27 kDa and adult worm regurge antigens in Egyptian patients.

Authors:  Hanan H Kamel; Ghada A Saad; Rania M Sarhan
Journal:  Korean J Parasitol       Date:  2013-04-25       Impact factor: 1.341

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.